The significance of follow-up serum uric acid levels in predicting all-cause mortality and cardiovascular mortality in peritoneal dialysis patients

Ther Apher Dial. 2023 Feb;27(1):83-90. doi: 10.1111/1744-9987.13892. Epub 2022 Jun 29.

Abstract

Background: This study aimed to analyze the change of serum uric acid (SUA) level post peritoneal dialysis (PD), and the correlation between follow-up SUA and prognosis in patients with PD.

Methods: A total of 1402 patients with PD were evaluated. We graded SUA levels into four grades at baseline, 6 months, 12 months, 18 months, and 24 months post PD, and then compared all-cause mortality and cardiovascular mortality among patients with different SUA grades at each time point. Kaplan-Meier and Cox proportional-hazards regression models were used in the analysis.

Results: The SUA levels were 7.97 ± 1.79, 7.12 ± 1.48, 7.05 ± 1.33, 7.01 ± 1.30, and 6.93 ± 1.26 mg/dl at baseline, 6, 12, 18, and 24 months, respectively. There was significant difference on all-cause mortality among patients with PD with different graded SUA levels at 6 months post PD (p = 0.010), and the all-cause mortality was lowest in patients with the grade of 5.65 mg/dl ≤ SUA <7.13 mg/dl.

Conclusion: SUA level decreased after PD during follow-up. At 6 months post PD, the grade of 5.65 mg/dl ≤ SUA <7.13 mg/dl was appropriate for better patients' survival.

Keywords: all-cause mortality; cardiovascular mortality; peritoneal dialysis; uric acid.

MeSH terms

  • Cardiovascular Diseases*
  • Follow-Up Studies
  • Humans
  • Peritoneal Dialysis* / adverse effects
  • Prognosis
  • Risk Factors
  • Uric Acid

Substances

  • Uric Acid